Here - EWMA 2013

E-POSTER PRESENTATIONS
EP 524
E-Poster: Leg Ulcer
Madura foot- as differential diagnosis of the chronic wounds of
the foot
Javorka Delic 1 , Spasoje Radovanovic 1
1 Serbian wound healing society (Belgrade, Serbia)
Introduction: Madura foot is endemic chronic wound, that is caused by pathogenic
fungi most commonly located on the foot. There is more wounds, fistulas of soft tissue
and bones and scar like star.
Methods: In Angiology Department (2011-2012.) we examined 5231 chronic wounds
(CWs) of which 403 were on the foot (8%). Gender reation was 1:2,5 (women-man).
Results: Etiological distribution of CWs on foot is next: Pressure wounds 121 patients
(35%),Venous ulceration 97 (24,5%),Mixtum arterious venous 12 (3%),Arterious 72
(18%),Postoperative 12 (3%),Traumatic 9 (2,3%),Iatrogenic 3 (0,5%), Diabetic foot 28
(4,5), Infective 7 (2 %),Vasculitis wounds 16 (4%),Others 3,5%.
Discussions: Etiological distribution of the CWsof foot are wery different from
distribution of CWs of leg, where is the mostly venous ulceration (65% of all). On foot is
the most common pressure, mixtum, arterious wounds, while the average years of
patients are 66 (62,89). The young patients 34,5 years (30-47) had infective and
vasculitis wounds. In that group we want to show Madoora foot, chronic wound
(Radovanovic, S. Botswana, Francastown Hospital,2012), as one of the examples of
diferential diagnosis of CWs of foots. The diagnosis is set by microbiology, histologic
rewiev,by X ray footage bone and clinical picture- specificity ulceration, swelling and
inflammation of the foot. Madura is treated with antibiotic and antimycotis, several
months.
Conclusion: Chronic foot wounds can be divided into two groups. Elderly patients have
pressure, arterious and mixtum ulcer while in younger patients group are infectious and
CWs in vasculitis.
Key words: Madura foot, Chronic wounds, Differential diagnosis
E-POSTER: LEG ULCER
EP 525
E-Poster: Leg Ulcer
USE OF A NEW ACTIVE SURFACE SURFACTANT GEL WITH SILVER
SULPHADIAZINE IN THE TREATMENT OF LEG SKIN ULCERS AND DIABETIC
FOOT LESIONS – ITALIAN MULTICENTER EXPERIENCE
Francesco Paolo Palumbo 1 , Simone Serantoni 2 , Franca Abbritti 3
1 Medical advisor (Palermo, Italy);
2 Casa di Cura Villa Fiorita (Prato, Italy);
3 U.O. Chirurgia Vascolare Ospedale G. Salvini (Garbagnate Milanese, Italy).
Aim: We evaluate the efficacy of this medication in the treatment of leg skin ulcers and
diabetic foot lesions. Presentation of data after follow-up at 180 days.
Methods: Prospective multicenter study evaluating 58 wounds (4 area groups: A 0-10
cm 2 / B 11- 20 cm 2 / C 21-100 cm 2 / D >100 cm 2 ) in 43 patients. Sex: 20 males and 23
females. Age: 26-91 yy, average 70.9. All patients underwent to an anamnestic and
clinical and instrumental evaluation. Data were collected using a schedule to detect
wound characteristics. QL index wad administred to all patients. The study was
completed in 30 days. We report results in the follow-up at 180 days.
Results: In almost all cases we observed an improvement of the wounds, indicated by:
a) regression of signs of infection and inflammation;
c) reduction of pain;
d) good compliance at dressing change;
e) reduction of malodour.
Discussion: The coordinators of the study all received the same training in vulnology
(all vascular surgeons).
Patients were selected according to conditions of the injury at time T0, regardless of time
of onset and treatment prior to enrollment date.
Conclusions:
• The gel interacts with the wound biofilm;
• It changes the characteristics of the non healing wounds;
• A sense of freshness after dressing change was reported in all lesions; no pain was
reported during application or dressing removal.
Easy to use, gel can be applied two or three times a week. No collateral effects both
local both systemic.
298